RG7652 - Roche
Chugai: Annual Report 2014 (Chugai) - Apr 2, 2015 - “Chugai has stopped development of RG7652, an anti-PSCK9 human monoclonal antibody, following Roche’s discontinuation of development” 
Discontinued • Dyslipidemia
http://www.chugai-pharm.co.jp/hc/ss/downloads/eAR2014_12_00.pdf?blobheader=application%2Fpdf&blobheadername1=content-disposition&blobheadervalue1=inline%3Bfilename%3DeAR2014_12_00.pdf&blobwhere=1396858804450&ssbinary=true
 
Apr 2, 2015
 
.